12-Sep-2026 - The Globe and Mail Evercore ISI Sticks to Its Hold Rating for Moderna (MRNA) Evercore ISI analyst Cory Kasimov maintained a Hold rating on Moderna today and set a price target of $80.00. According to TipRanks, Kasimov is a 5-star analyst with an average return of 20.5% and a ...
9-Sep-2026 - Yahoo Finance Moderna Set for 3 Near-Term INT Data Readouts, UBS Says Moderna (MRNA) is set for three data readouts on its individualized neoantigen therapies, or INT, in the near term, serving as potential stock catalysts for the company, UBS Secur ...
4-Sep-2026 - The Globe and Mail Why Moderna (MRNA) Stock Is Down Today Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 2.9% in the afternoon session after Rothschild & Co Redburn analyst Simon Baker downgraded the company to Sell from Neutral on valuation ...
Latest MRNA Trades by Congress Members
19-AUG-2026 - Maria Elvira Salazar, FL (District 27) purchased between $1,001 and $15,000.
12-Sep-2026 - The Globe and Mail Evercore ISI Sticks to Its Hold Rating for Moderna (MRNA) Evercore ISI analyst Cory Kasimov maintained a Hold rating on Moderna today and set a price target of $80.00. According to TipRanks, Kasimov is a 5-star analyst with an average return of 20.5% and a ...
9-Sep-2026 - Yahoo Finance Moderna Set for 3 Near-Term INT Data Readouts, UBS Says Moderna (MRNA) is set for three data readouts on its individualized neoantigen therapies, or INT, in the near term, serving as potential stock catalysts for the company, UBS Secur ...
4-Sep-2026 - The Globe and Mail Why Moderna (MRNA) Stock Is Down Today Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 2.9% in the afternoon session after Rothschild & Co Redburn analyst Simon Baker downgraded the company to Sell from Neutral on valuation ...
